AMPTS sales accelerate into 2011

Sales of Bioprocess Control’s Automatic Methane Potential Test System or AMPTS continue to accelerate as the company enters into 2011. Customers from over 20 countries within the Americas, EMEA and Asia Pacific regions, now use the AMPTS in their research and commercial activities. We are very pleased with this development, as it not only shows the global appeal of this technology, but also validates Bioprocess Control’s leading position in the market with regards to value for money, performance & features, and quality & level of service. We see this trend continuing through 2011, as the AMPTS continues to be the technology of choice for both research and commercial applications.